, Volume 37, Issue 1, pp 13–19 | Cite as

A study of acetazolamide-induced changes in cerebral blood flow using99mTc HMPAO SPECT in patients with cerebrovascular disease

  • S. Asenbaum
  • A. Reinprecht
  • T. Brücke
  • S. Wenger
  • L. Podreka
  • L. Deecke
Diagnostic Neuroradiology


For semiquantification of SPECT studies we tried to calculate cerebral99mTc-HMPAO uptake related to injected dose and estimated brain volume. The method was applied to SPECT investigations of 27 patients who had a least one ischaemic attack and a confirmed 80–100% stenosis of the corresponding internal carotid artery (ICA). Vascular reactivity was tested by parenteral administration of acetazolamide (AZ). Increase in HMPAO uptake after AZ was evident in both hemispheres, although the increase (AZ effect) was significantly lower in the affected hemisphere (+24% versus +28%). No interhemispheric uptake differences were seen in patients with largely normal SPECT studies, although local asymmetries in HMPAO deposition were visible. Patients with low density lesions on CT and with a well-demarcated lesion in the same location on SPECT revealed interhemispheric uptake differences, with lower uptake on the affected side. This was not due solely to alterations in the lesion, but also to reduced HMPAO uptake and AZ effect in the surrounding area. The AZ effect showed no correlation with angiographic findings, indicating no major haemodynamic influence of the ICA stenosis on cerebral hemisphere perfusion. Calculated cerebral HMPAO uptake changes after AZ administration were in good accordance with absolute cerebral blood flow measurements, and made interindividual comparisons possible. However, as changes in the area around an infarct or local reduction in vascular reserve may not be reproduced adequately by uptake calculations, visual inspection is still necessary.

Key words

Cerebrovascular disease Single photon emission computed tomography Acetazolamide 99mTc HMPAO 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Buell U, Moser EA, Schmiedek P, Leinsinger G, Kreisig T, Kirsch CM, Einhäupl K (1984) Dynamic SPECT with Xe-133: regional cerebral blood flow in patients with unilateral cerebrovascular disease: concise communication. J Nucl Med 25: 441–446Google Scholar
  2. 2.
    Heuser D, Astrup J, Lassen NA, Betz E (1975) Brain carbonic acid acidosis after acetazolamide. Acta Physiol Scand 93: 385–390Google Scholar
  3. 3.
    Hauge A, Nicolaysen G, Thoresen M (1983) Acute effects of acetazolamide on cerebral blood flow in man. Acta Physiol Scand 117: 233–239Google Scholar
  4. 4.
    Vorstrup S, Henriksen L, Paulson OB (1984) Effect of acetazolamide on cerebral blood flow and cerebral metabolic rate for oxygen. J Clin Invest 74: 1634–1639Google Scholar
  5. 5.
    Gibbs JM, Wise RJS, Leenders KL, Jones T (1984) Evaluation of cerebral perfusion reserve in patients with carotid artery occlusion. Lancet I: 318–314Google Scholar
  6. 6.
    Powers WJ, Raichle ME (1985) Positron emission tomography and its application to the study of cerebrovascular disease in man. Stroke 16: 361–374Google Scholar
  7. 7.
    Hojer-Pedersen E (1987) Effect of acetazolamide on cerebral blood flow in subacute and chronic cerebrovascular disease. Stroke 18: 887–891Google Scholar
  8. 8.
    Sullivan HG, Kingsbury TB, Morgan ME, Jeffcoat RD, Allison JD, Goode JJ, McDonell DE (1987) The rCBF response to Diamox in normal subjects and cerebrovascular disease patients. J Neurosurg 67: 525–534Google Scholar
  9. 9.
    Chollet F, Celsis P, Clanet M, Guiraud-Chaumeil B, Rascol A, Marc-Vergnes J-P (1989) SPECT study of cerebral blood flow reactivity after acetazolamide in patients with transient ischemic attacks. Stroke 20: 458–464Google Scholar
  10. 10.
    Di Piero V, Pozzilli C, Pantano P, Grasso MG, Fieschi C (1989) Acetazolamide effects on cerebral blood flow in acute reversible ischemia. Acta Neurol Scand 80: 35–40Google Scholar
  11. 11.
    Vorstrup S, Brun B, Lassen NA (1986) Evaluation of the cerebral vasodilatory capacity by the acetazolamide test before EC-IC bypass surgery in patients with occlusion of the internal carotid artery. Stroke 17: 1291–1986Google Scholar
  12. 12.
    Raynaud C, Rancurel G, Tzourio N, Soucy JP, Baron JC, Pappata S, Cambon H, Mazoyer B, Lassen NA, Cabanis E, Majdalani A, Bourdoiseau M, Ricard S, Bourguignon M, Syrota A (1989) SPECT analysis of recent cerebral infarction. Stroke 20: 192–204Google Scholar
  13. 13.
    Knop J, Thie A, Fuchs C, Siepmann G, Zeumer H (1992)99mTc-HMPAO-SPECT with acetazolmide challenge to detect hemodynamic comprise in occlusive cerebrovascular disease. Stroke 23: 1733–1742Google Scholar
  14. 14.
    Podreka I, Goldenberg G, Baumgartner C, Lang W, Steiner M, Schmidbauer M, Suess E, Brücke T, Asenbaum S, Deecke L (1989) HMPAO brain uptake in youngh normal subjects: gender differences and hemispheric asymmetries. J Cereb Blood Flow Metab 9 [Suppl 1]: S202Google Scholar
  15. 15.
    Bellini S, Piacentini M, Cafforio C, Rocca F (1979) Compensation of tissue absorption in emission tomography. IEEE Trans Acous Speech Sign Proc ASSP 27: 213–218Google Scholar
  16. 16.
    Podreka I, Suess E, Goldenberg G, Steiner M, Brücke T, Lang W, Neirinckx RD, Deecke L (1987) Initial experience with technetium-99m HM-PAO brain SPECT. J Nucl Med 28: 1657–1666Google Scholar
  17. 17.
    Holl K, Nemati MN, Haubitz B, Majewski A, Gaab MR, Becker H, Dietz H (1991) Xenon-CT und Bestimmung der zerebrovaskulären Reserve mit Acetazolamide (DiamoxR). In: Becker H, Gaab MR (eds) Hirndurchblutung und zerebrovaskuläre Reservekapazität. Methoden und klinische Anwendung. Thieme, Stuttgart, pp 57–64Google Scholar
  18. 18.
    Podreka I, Asenbaum S, Brücke T, Wenger S, Lang W, Goldenberg G, Schmidbauer M, Deecke L (1991) Intraindividual reproducibility of HMPAO brain uptake. J Cereb Blood Flow Metabol 11 [Suppl 1]: S776Google Scholar
  19. 19.
    Sabatini U, Celsis P, Viallard G, Rascol A, Marc-Vergnes J-P (1991) Quantitative assessment of cerebral blood volume by single-photon emission computed tomography. Stroke 22: 324–330Google Scholar
  20. 20.
    Burt RW, Witt RM, Cikrit DF, Reddy RV (1992) Carotid artery disease: evaluation with acetazolamide-enhanced Tc-99m HMPAO SPECT. Radiology 182: 461–466Google Scholar
  21. 21.
    Lassen NA, Andersen AR, Friberg H, Neirinckx RD (1987) Technetium-99m-HMPAO as a tracer of cerebral blood flow distribution: a kinetic analysis. J Cereb Blood Flow Metab 7 [Suppl 1]: S535Google Scholar
  22. 22.
    Heiss W-D, Herholz K, Podreka I, Neubauer I, Pietrzyk U (1990) Comparison of (99mTc)HMPAO SPECT with (18F)Fluoromethane PET in cerebrovascular disease. J Cereb Blood Flow Metab 10: 687–697Google Scholar
  23. 23.
    Astrup J, Symon L, Branston NM, Lassen NA (1977) Cortical evoked potential and extracellular K+ and H+ at critical levels of brain ischaemia. Stroke 8: 51–57Google Scholar
  24. 24.
    Baron JC, Rougemont D, Bousser MG, Lebrun-Grandie P, Iba-Zizen MT, Chiras J (1983) Local CBF, oxygen extraction fraction (OEF) and CMRO2: prognostic value in recent supratentornal infarction in humans. J Cereb Blood Flow Metab 3 [Suppl 1]: S1-S2Google Scholar
  25. 25.
    Lenzi GL, Frackowiak RSJ, Jones T (1982) Cerebral oxygen metabolism and blood flow in human cerebral ischemic infarction. J Cereb Blood Flow Metab 2: 321–335Google Scholar
  26. 26.
    Heiss W-D, Huber M, Fink GR, Herholz K, Pietrzyk U, Wagner R, Wienhard K (1992) Progressive derangement of periinfarct viable tissue in ischemic stroke. J Cereb Blood Flow Metab 12: 193–203Google Scholar
  27. 27.
    Strong AJ, Gibson G, Miller SA, Venables GS (1988) Changes in vascular and metabolic reactivity as indices of ischaemia in the penumbra. J Cerb Blood Flow Metab 8: 79–88Google Scholar
  28. 28.
    Sette G, Baron JC, Mazoyer B, Levasseur M, Pappata S, Crouzel C (1989) Local brain haemodynamics and oxygen metabolism in cerebrovascular disease. Brain 112: 931–951Google Scholar
  29. 29.
    Takano T, Nagatsuka K, Ohnishi Y, Takamitsu Y, Matsuo H, Matsumoto M, Kimura K, Kamada T (1988) Vascular response to carbon dioxide in areas with and without diaschisis in patients with small, deep hemispheric infarction. Stroke 19: 840–845Google Scholar
  30. 30.
    Powers WJ (1991) Cerebral hemodynamics in ischemic cerebrovascular disease. Ann Neurol 29: 231–240Google Scholar

Copyright information

© Springer-Verlag 1995

Authors and Affiliations

  • S. Asenbaum
    • 1
  • A. Reinprecht
    • 1
  • T. Brücke
    • 1
  • S. Wenger
    • 1
  • L. Podreka
    • 1
  • L. Deecke
    • 1
  1. 1.Neurological ClinicUniversity of ViennaViennaAustria

Personalised recommendations